New ‘off-the-shelf’ immunotherapy shows promise for treating high-risk childhood leukaemia

Published on September 3, 2025

Scientists at the University of Oxford, together with colleagues at Imperial College London and the University of Glasgow, have developed a new type of immunotherapy that could improve outcomes for infants and children with high-risk leukaemia.